|Chardan||Geulah Livshits, Ph.D.|
|Cowen||Phil Nadeau Ph.D., Marc Frahm Ph.D.|
|Evercore ISI||Josh Schimmer M.D.|
|H.C. Wainwright||Douglas Tsao|
|Mizuho Securities||Uy Ear|
|Morgan Stanley||Michael E. Ulz, Matthew Harrison|
|Wells Fargo||Derek Archila|
Cabaletta Bio, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Cabaletta Bio, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Cabaletta Bio, Inc. or its management. Cabaletta Bio, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.